Status:
TERMINATED
First in Man Study With SLV342
Lead Sponsor:
Abbott Products
Collaborating Sponsors:
Quintiles, Inc.
Conditions:
Pharmacokinetics
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
First in man study with single and multiple rising doses with SLV342
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Healthy
- Exclusion Criteria
- Not healthy
Exclusion
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00985478
Start Date
January 1 2010
End Date
June 1 2010
Last Update
August 25 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 61142
London, United Kingdom, SE1 1YR